THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

Udho Thadani to Tissue Plasminogen Activator

This is a "connection" page, showing publications Udho Thadani has written about Tissue Plasminogen Activator.
Connection Strength

0.140
  1. Comparison of pharmacokinetics of lanoteplase and alteplase during acute myocardial infarction. Clin Pharmacokinet. 2002; 41(6):445-52.
    View in: PubMed
    Score: 0.049
  2. Evaluation of a weight-adjusted single-bolus plasminogen activator in patients with myocardial infarction: a double-blind, randomized angiographic trial of lanoteplase versus alteplase. Circulation. 1998 Nov 17; 98(20):2117-25.
    View in: PubMed
    Score: 0.039
  3. Myocardial infarct artery patency and reocclusion rates after treatment with duteplase at the dose used in the International Study of Infarct Survival-3. Burroughs Wellcome Study Group. Am J Cardiol. 1993 Feb 15; 71(5):386-92.
    View in: PubMed
    Score: 0.026
  4. Evaluation of a prolonged infusion of recombinant tissue-type plasminogen activator (Duteplase) in preventing reocclusion following successful thrombolysis in acute myocardial infarction. Am J Cardiol. 1992 May 01; 69(14):1120-7.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES